Singulex, which develops innovative tests for the diagnosis and monitoring of chronic diseases, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The
Read more here:
Singulex files for a $86 million IPO
Singulex, which develops innovative tests for the diagnosis and monitoring of chronic diseases, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The
Read more here:
Singulex files for a $86 million IPO